相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pregabalin abuse and dependence in Germany: results from a database query
Maximilian Gahr et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
New approaches to the pharmacological management of generalized anxiety disorder
Massimiliano Buoli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
Dan J. Stein et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder
F. W. Lohoff et al.
PHARMACOGENOMICS JOURNAL (2013)
Anxiety disorders and drug dependence: Evidence on sequence and specificity among adults
Renee D. Goodwin et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2013)
Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain
Marina De Salas-Cansado et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2013)
Characterizing and understanding body weight patterns in patients treated with pregabalin
Javier Cabrera et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Pregabalin Treatment for Peripheral Neuropathic Pain A Review of Safety Data from Randomized Controlled Trials Conducted in Japan and in the West
Setsuro Ogawa et al.
DRUG SAFETY (2012)
Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence
Panagiotis Oulis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Off-label uses of trazodone: a review
Letizia Bossini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment
Karl Rickels et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care
Borwin Bandelow et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2012)
Agomelatine Prevents Relapse in Generalized Anxiety Disorder: A 6-Month Randomized, Double-Blind, Placebo-Controlled Discontinuation Study
Dan J. Stein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
Giovanni Martinotti et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial
Sallie J. Hadley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Mode of Action Associated With Development of Hemangiosarcoma in Mice Given Pregabalin and Assessment of Human Relevance
Kay A. Criswell et al.
TOXICOLOGICAL SCIENCES (2012)
The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety
M. Justin Kim et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
ALTERED CEREBRAL BLOOD FLOW PATTERNS ASSOCIATED WITH PATHOLOGIC WORRY IN THE ELDERLY
Carmen Andreescu et al.
DEPRESSION AND ANXIETY (2011)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study
John H. Greist et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review
Miny Samuel et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Evidence-based pharmacological treatment of generalized anxiety disorder
David S. Baldwin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Polymorphic variation at the serotonin 1-A receptor gene is associated with comorbid depression and generalized anxiety
Esther Molina et al.
PSYCHIATRIC GENETICS (2011)
Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data
Fabrizio Schifano et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2011)
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial
Giovanni Martinotti et al.
ADDICTION (2010)
Pregabalin Abuse, Dependence, and Withdrawal: A Case Report
Martin Grosshans et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Howard N. Bockbrader et al.
CLINICAL PHARMACOKINETICS (2010)
A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system
Sofie Schwan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome
M. Di Nicola et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder
R. Bruce Lydiard et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Salivary Cortisol Levels in Persons With and Without Different Anxiety Disorders
Sophie A. Vreeburg et al.
PSYCHOSOMATIC MEDICINE (2010)
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
Montserrat Vera-Llonch et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2010)
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
Siegfried Kasper et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder: 6-Month Follow-Up
Alexander Bystritsky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder
A. Carlo Altamura et al.
CNS SPECTRUMS (2008)
Human and economic burden of generalized anxiety disorder
Deborah L. Hoffman et al.
DEPRESSION AND ANXIETY (2008)
Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies
Dan J. Stein et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Long-term efficacy of pregabalin in generalized anxiety disorder
Douglas Feltner et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials
Stefan G. Hofmann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A preliminary study of fMRI-Guided rTMS in the treatment of generalized anxiety disorder
Alexander Bystritsky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Bodyweight gain under pregabalin therapy in epilepsy: Mitigation by counseling patients?
Christian Hoppe et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials
P. Bech
PHARMACOPSYCHIATRY (2007)
Ca2+ channel α2δ ligands:: novel modulators of neurotransmission
David J. Dooley et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders
Daniel M. Tassone et al.
CLINICAL THERAPEUTICS (2007)
Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium
Torbjorn Tomson et al.
CLINICAL PHARMACOKINETICS (2007)
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: A 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine
Stuart A. Montgomery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Medication augmentation after the failure of SSRIs for depression
MH Trivedi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation:: Does a fetal accumulation occur during pregnancy?
I Öhman et al.
EPILEPSIA (2005)
Pregabalin for treatment of generalized anxiety disorder - A 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam
K Rickels et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Efficacy of pregabalin in the treatment of generalized anxiety disorder - Double-blind, placebo-controlled comparison of BID versus TID dosing
RB Pohl et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
B Bandelow et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2004)
Generalized anxiety disorder: Acute and chronic treatment
MA Rynn et al.
CNS SPECTRUMS (2004)
Pregabalin for the treatment of postherpetic neuralgia - A randomized, placebo-controlled trial
RH Dworkin et al.
NEUROLOGY (2003)
Pharmacokinetics of pregabalin in subjects with various degrees of renal function
EJ Randinitis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pregabalin in generalized anxiety disorder: A placebo-controlled trial
AC Pande et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Cognitive theories of generalized anxiety disorder
DE Aikins et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2001)
分享论文
